Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance.
Triggiani L, Mazzola R, Tomasini D, Bruni A, Alicino G, Matrone F, Bortolus R, Francolini G, Detti B, Magli A, Bonù ML, Ingrosso G, Lancia A, Trippa F, Maranzano E, Franzese C, Ghirardelli P, Vavassori V, Scorsetti M, Alongi F, Magrini SM. Triggiani L, et al. Among authors: matrone f. Med Oncol. 2021 May 18;38(6):72. doi: 10.1007/s12032-021-01518-6. Med Oncol. 2021. PMID: 34008151 Free PMC article.
Preoperative intensity-modulated radiotherapy with a simultaneous integrated boost combined with Capecitabine in locally advanced rectal cancer: short-term results of a multicentric study.
Lupattelli M, Matrone F, Gambacorta MA, Osti M, Macchia G, Palazzari E, Nicosia L, Navarria F, Chiloiro G, Valentini V, Aristei C, De Paoli A. Lupattelli M, et al. Among authors: matrone f. Radiat Oncol. 2017 Aug 22;12(1):139. doi: 10.1186/s13014-017-0870-4. Radiat Oncol. 2017. PMID: 28830475 Free PMC article.
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study.
Triggiani L, Mazzola R, Magrini SM, Ingrosso G, Borghetti P, Trippa F, Lancia A, Detti B, Francolini G, Matrone F, Bortolus R, Fanetti G, Maranzano E, Pasqualetti F, Paiar F, Bonù ML, Magli A, Bruni A, Mazzeo E, Franzese C, Scorsetti M, Alongi F, Jereczek-Fossa BA, Ost P, Buglione M. Triggiani L, et al. Among authors: matrone f. World J Urol. 2019 Dec;37(12):2631-2637. doi: 10.1007/s00345-019-02717-7. Epub 2019 Mar 11. World J Urol. 2019. PMID: 30859273
Partial prostate re-irradiation for the treatment of isolated local recurrence of prostate cancer in patients previously treated with primary external beam radiotherapy: short-term results of a monocentric study.
Matrone F, Revelant A, Fanetti G, Polesel J, Chiovati P, Avanzo M, De Renzi F, Colombo CB, Arcicasa M, De Paoli A, Franchin G, Bortolus R. Matrone F, et al. Neoplasma. 2021 Jan;68(1):216-226. doi: 10.4149/neo_2020_200622N651. Epub 2020 Oct 7. Neoplasma. 2021. PMID: 33030959
Postoperative radiotherapy after upfront radical prostatectomy: debated issues at a turning point-a survey exploring management trends on behalf of AIRO (Italian Association of Radiotherapy and Clinical Oncology).
Francolini G, Timon G, Matrone F, Marvaso G, Nicosia L, Ognibene L, Vinciguerra A, Trodella LE, Franzese C, Borghetti P, Jereczek-Fossa BA, Arcangeli S. Francolini G, et al. Among authors: matrone f. Clin Transl Oncol. 2021 Dec;23(12):2568-2578. doi: 10.1007/s12094-021-02665-y. Epub 2021 Jul 21. Clin Transl Oncol. 2021. PMID: 34286475
Attitudes, practices and perspectives on imaging strategies in prostate cancer: a national cross-sectional survey involving expert radiation oncologists on behalf of AIRO (Italian association of radiotherapy and clinical oncology) GU group.
Lucchini R, Francolini G, Matrone F, Timon G, Franzese C, Marvaso G, Borghetti P, Nicosia L, Trodella LE, Vinciguerra A, Jereczek-Fossa BA, Arcangeli S. Lucchini R, et al. Among authors: matrone f. Med Oncol. 2021 Nov 5;39(1):3. doi: 10.1007/s12032-021-01597-5. Med Oncol. 2021. PMID: 34739613
The role of stereotactic body radiation therapy and its integration with systemic therapies in metastatic kidney cancer: a multicenter study on behalf of the AIRO (Italian Association of Radiotherapy and Clinical Oncology) genitourinary study group.
Franzese C, Marvaso G, Francolini G, Borghetti P, Trodella LE, Sepulcri M, Matrone F, Nicosia L, Timon G, Ognibene L, Vinciguerra A, Alongi F, Bortolus R, Corti L, Ramella S, Magrini SM, Livi L, Jereczek-Fossa BA, Scorsetti M, Arcangeli S. Franzese C, et al. Among authors: matrone f. Clin Exp Metastasis. 2021 Dec;38(6):527-537. doi: 10.1007/s10585-021-10131-w. Epub 2021 Nov 8. Clin Exp Metastasis. 2021. PMID: 34748125
35 results